Skip to main content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

An official website of the United States government
Grant Details

Grant Number: 1R61CA297714-01 Interpret this number
Primary Investigator: Wackowski, Olivia
Organization: Rutgers Biomedical And Health Sciences
Project Title: Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale
Fiscal Year: 2024


Abstract

PROJECT SUMMARY/ABSTRACT Tobacco use remains a leading cause of premature disease and death in the United States, including those attributable to cancer. In a landmark racketeering lawsuit filed by the US Department of Justice in 1999, several major tobacco manufacturers were found guilty of consumer fraud, which included deceptive tactics such as lying to consumers about the deadly effects of cigarettes, manipulating cigarettes to make them more addictive, and marketing their products to young people. To help remedy these actions, the court ordered the manufacturers to run a series of “corrective statements” in several communication channels in the US, including television, newspapers, and signage displays in stores at the point-of-sale. After nearly two decades of tobacco industry litigation to delay the corrective statement requirement in retail settings – one of the industry’s most valuable marketing channels – a 2022 court order finally mandated that the signs be posted from October 1, 2023 through June 30, 2025, a 21-month period. More than 200,000 retailers that have marketing agreements with the affected manufacturers – approximately 2 in 3 retailers nationwide – are required to display these large, eye-catching signs that inform consumers about the health risks of tobacco and the tobacco industry’s history of deception. While this historic retail-based intervention has the potential to positively impact public health, critical questions remain about the nature of its implementation, reach, and effects on consumers, including impacts on health equity. For example, it is unknown how implementation features of the signage (e.g., presence, number, placement) may vary by store type and neighborhood; if, and to what extent, consumers notice and retain the corrective messages; and whether exposure impacts tobacco knowledge, beliefs, intentions and behaviors (e.g., quit attempts). The finite window of intervention delivery offers a unique and time-sensitive opportunity to answer these questions, which may inform future large-scale tobacco information dissemination efforts, as well as identify subpopulations who may benefit from supplemental health education programs or other services. The specific aims of the study are to: (1) Characterize both implementation and reach by collecting detailed information about corrective statement implementation features through a retailer audit study. Supplemental analyses will calculate the prevalence/density of retailers required to display the statements across the United States. (2) Use eye- tracking methodologies to explore attention to the corrective statements (i.e., reach and impact) in the context of real-world exposures. (3) Field longitudinal surveys of adults and youth to examine reach and impact of the statements among a nationally representative sample, including reported exposures, message perceptions, and impact on tobacco knowledge, attitudes, intentions and behaviors.



Publications

Error Notice

The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.

We apologize for the inconvenience.
- The DCCPS Team.

Back to Top